Humana AB (publ)

Humana AB (publ), founded in 2001 and headquartered in Stockholm, Sweden, offers a wide range of individual and family care services across Sweden, Finland, Norway, and Denmark, serving both children and adults. The company's operations are divided into five core segments. The Individual & Family segment delivers comprehensive care and treatment for individuals experiencing psychosocial disorders, mental health conditions, and functional impairments. This includes residential care homes, interim and permanent family care placements, specialized residential solutions, outpatient services, assisted living facilities, specially adapted housing for individuals with functional impairments, and special education schools. The Personal Assistance segment provides dedicated support and assistance to individuals living with functional impairments. The Elderly Care segment specializes in residential care facilities for seniors. Its Finland segment offers individual and family care services for children, young people, and families dealing with psychiatric diagnoses or psychosocial disorders, alongside specialized housing for individuals with functional impairments, and both residential and day care for seniors. Finally, the Norway segment provides individual and family care, personal assistance, and specialized housing for individuals with functional impairments.

Humana AB (publ) trades as HUM.ST on STO. The company is classified in Healthcare / Medical - Care Facilities and reports in SEK.

The current profile places the business in Medical - Care Facilities. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Humana AB (publ) can be compared against peers such as BICO Group AB (publ), BioInvent International AB (publ), Carasent AB (publ), Devyser Diagnostics AB (publ), Egetis Therapeutics AB (publ), Hansa Biopharma AB (publ).

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $2.29B, beta of 0.08, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

HUM.ST currently shows total debt of N/A and beta of 0.08. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.humana.se

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.